{"schema_version":"secwatch.filing_event.v1","accession":"0001021771-26-000091","form_type":"8-K","ticker":"BRTX","cik":"0001505497","company_name":"BioRestorative Therapies, Inc.","filed_at":"2026-06-12T20:56:39+00:00","discovered_at":"2026-06-12T20:58:01.415498+00:00","generated_at":"2026-06-12T20:58:29.536337+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRestorative Therapies enters $1M revolving loan at 12% with Bowery Group; board overhaul with 3 new directors","bullets":["Entered $1,000,000 revolving loan agreement with Bowery Group LLC at 12% interest, 16% default rate, 1-year maturity.","Three directors (Francisco Silva, Nickolay Kukekov, Patrick F. Williams) resigned effective June 11, 2026.","Lender designees Mika Grasso, Katharyn Field, Jatinder Dhaliwal appointed to board as Class II, I, III directors respectively.","Loan proceeds for general corporate purposes; lender controls board composition via appointment rights.","Mr. Grasso chairs Audit Committee; Ms. Field chairs Nominating; Mr. Dhaliwal on all three committees."],"urls":{"canonical":"https://secwatch.observer/filing/0001021771-26-000091","json":"https://secwatch.observer/filing/0001021771-26-000091.json","markdown":"https://secwatch.observer/filing/0001021771-26-000091.md","text":"https://secwatch.observer/filing/0001021771-26-000091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/brtx-20260612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T20:58:29.536337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"245b082947","claim":"Jatinder Dhaliwal was appointed as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"55acad49c4","claim":"Nickolay Kukekov resigned as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"a1c5299cbe","claim":"Francisco Silva resigned as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b371e0781c","claim":"Patrick F. Williams resigned as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"Effective June 11, 2026, pursuant to the Revolving Loan Agreement, Francisco Silva, Nickolay Kukekov and Patrick F. Williams resigned as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b823f1936e","claim":"Mika Grasso was appointed as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"db329d631f","claim":"Katharyn Field was appointed as Director at BioRestorative Therapies, Inc..","evidence_excerpt":"the remaining members of the Company’s Board of Directors (the “Board”) appointed Mika Grasso, Katharyn Field and Jatinder Dhaliwal (collectively, the “New Directors”), designees of the Lender, as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b4a191505d6cf4badf4b8d8b65623b1ef2c9ea0c","claim":"BioRestorative Therapies, Inc. entered into Revolving Loan Agreement with Bowery Group LLC valued at Loans up to $1,000,000 aggregate principal; interest rate 12% per annum; default rate 16% per annum; (effective 2026-06-10).","evidence_excerpt":"On June 10, 2026, BioRestorative Therapies, Inc. (the “Company”) entered into a Revolving Loan Agreement (the “Revolving Loan Agreement”) with Bowery Group LLC (the “Lender”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177126000091/0001021771-26-000091-index.htm","confidence":0.99,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Bowery Group LLC"},{"label":"Value","value":"Loans up to $1,000,000 aggregate principal; interest rate 12% per annum; default rate 16% per annum;"},{"label":"Effective","value":"2026-06-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}